Cargando…
GSTM1 and GSTT1 polymorphisms and nasopharyngeal cancer risk: an evidence-based meta-analysis
BACKGROUND: Previous evidence implicates polymorphisms of GSTM1 and GSTT1, candidates of phase II enzymes, as risk factors for various cancers. A number of studies have conducted on the association of GSTM1 and GSTT1 polymorphism with susceptibility to nasopharyngeal carcinoma (NPC). However, incons...
Autores principales: | Zhuo, Xianlu, Cai, Lei, Xiang, Zhaolan, Li, Qi, Zhang, Xueyuan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2669055/ https://www.ncbi.nlm.nih.gov/pubmed/19338664 http://dx.doi.org/10.1186/1756-9966-28-46 |
Ejemplares similares
-
Cancer Risk and GSTM1 and GSTT1 Polymorphisms
por: Cetta, Francesco, et al.
Publicado: (2009) -
GSTM1 and GSTT1 polymorphisms contribute to renal cell carcinoma risk: evidence from an updated meta-analysis
por: Huang, Wentao, et al.
Publicado: (2015) -
GSTM1, GSTT1 and GSTP1 Polymorphisms in the Korean Population
por: Cho, Hyun-Jung, et al.
Publicado: (2005) -
GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis
por: Yu, Cui, et al.
Publicado: (2016) -
Genetic Polymorphisms of Glutathione S-Transferase Genes GSTM1, GSTT1 and Risk of Hepatocellular Carcinoma
por: Song, Kang, et al.
Publicado: (2012)